Answers are grounded in this paper and cite their sources.
Dysregulation of cancer cell metabolism contributes to abnormal cell growth, the biological end point of cancer. We review here numerous affected oncogenes and metabolic pathways common in cancer and how they contribute to cancer pathogenesis and malignancy. This review also discusses various pharmacological manipulations that take advantage of these metabolic abnormalities and the current targeted therapies that have arisen from this research.
No takes yet. Share an insight, caveat, or question.
Counihan et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: